Reporting owner · CIK 0001757533

Reicin Alise

Visual SEC Form 4 history across 2 companies, 7 transactions and 5 filings.

CEOChief Executive OfficerTectonic Therapeutic, Inc.
Open-market mix
Filings5Form 4 records
Buying$00 purchases
Selling$00 sales
Net value$0Buys minus sells
Companies23 securities
Most recentSep 03, 2026grant

Open-market buy performance

90-day forward return on this insider's open-market purchases

90d forward
Forward return is not available yet

We compute this from each buy's stock performance 90 days after the transaction. The price history is still being populated for this insider's their open-market buys, so the average and median will appear here once the daily price refresh has covered the relevant trading days.

Monthly open-market activity

Reported purchase and sale transaction counts

Buys Sells
No open-market purchases or sales in this history.

Net value flow

Buys minus sells

Feb 25
$0
Dec 25
$0
Feb 26
$0
Jun 26
$0
Sep 26
$0

Transaction texture

Ownership and ticket size

Average P/S size
Median P/S size
Direct7
Indirect0
Sep 03, 2026grant

Latest Form 4 facts

Quick context from source filings

Latest transaction

No latest transaction fact is available.

Latest buy

No open-market insider purchase is available.

Latest sale

No open-market insider sale is available.

TickerInsiderRoleTypeSharesValueCodeSignals90d returnFiledTrans date
TECXREICIN ALISE
CEO
grant69.2k$0A0.0%09/0809/03
SANAREICIN ALISE
DIR
grant90.0k$0A06/0506/04
TECXREICIN ALISE
CEO
withholding4.10k-$9.52MF+30.7%02/1002/04
TECXREICIN ALISE
CEO
exercise10.9kM+47.2%01/0512/31/2025
TECXREICIN ALISE
CEO
exercise10.9k$2.60MM+47.2%01/0512/31/2025
TECXREICIN ALISE
CEO
grant101k$0A02/06/202502/04/2025
TECXREICIN ALISE
CEO
grant36.0k$0A02/06/202502/04/2025

Reicin Alise Insider Activity FAQ

SEC Form 4 context

Who is Reicin Alise?

Reicin Alise is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001757533.

Which companies has Reicin Alise reported transactions for?

Tectonic Therapeutic, Inc., Sana Biotechnology, Inc.

When was Reicin Alise's latest insider buy?

No open-market insider purchase is available for this period.

When was Reicin Alise's latest insider sale?

No open-market insider sale is available for this period.

Where can I see the original SEC filings?

Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.

Are performance metrics included?

This version does not calculate win rates, forward returns, benchmark-adjusted returns, or high-conviction scores.